Toronto-Dominion Bank »

Sab Biotherapeutics shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Sab Biotherapeutics (SABSW) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $5 200 0.03

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Cibc Cad (CM)
Tesla Motors (TSLA)
Amazon (AMZN)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
Spdr Gold Tr Gold Shs (GLD)
Bank Of Montreal Cadcom (BMO)
Meta Platforms Cl A (META)
Tc Energy Corp (TRP)
UnitedHealth (UNH)

View all positions for Toronto-Dominion Bank

Top funds holding Sab Biotherapeutics

LMR Partners
Morgan Stanley
Clear Street
Millennium Management
Susquehanna International
UBS Group
Walleye Trading
Wolverine Asset Management
Goss Wealth Management
Toronto-Dominion Bank

View all funds holding Sab Biotherapeutics